Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 874,000,000	$ 4,030,000,000
Receivables:
Receivable from the sale of IQOS System commercialization rights	1,772,000,000	1,721,000,000
Other	63,000,000	48,000,000
Inventories:
Leaf tobacco	599,000,000	704,000,000
Other raw materials	209,000,000	186,000,000
Work in process	29,000,000	24,000,000
Finished product	354,000,000	266,000,000
Inventory, net	1,191,000,000	1,180,000,000
Other current assets	438,000,000	241,000,000
Total current assets	4,338,000,000	7,220,000,000
Property, plant and equipment, at cost	4,487,000,000	4,427,000,000
Less accumulated depreciation	2,861,000,000	2,819,000,000
Property, plant and equipment, net	1,626,000,000	1,608,000,000
Goodwill	6,790,000,000	5,177,000,000
Other intangible assets, net	13,749,000,000	12,384,000,000
Investments in equity securities ($0 million and $250 million at June 30, 2023 and December 31, 2022, respectively, measured at fair value)	9,643,000,000	9,600,000,000
Other assets	1,005,000,000	965,000,000
Total Assets	37,151,000,000	36,954,000,000
Liabilities
Short-term borrowings	2,000,000,000	0
Current portion of long-term debt	1,121,000,000	1,556,000,000
Accounts payable	454,000,000	552,000,000
Accrued liabilities:
Marketing	691,000,000	599,000,000
Settlement charges	1,562,000,000	2,925,000,000
Other	1,459,000,000	1,299,000,000
Deferred gain from the sale of IQOS System commercialization rights	2,700,000,000	0
Dividends payable	1,677,000,000	1,685,000,000
Total current liabilities	11,664,000,000	8,616,000,000
Long-term debt	24,074,000,000	25,124,000,000
Deferred income taxes	2,646,000,000	2,897,000,000
Accrued pension costs	128,000,000	133,000,000
Accrued postretirement health care costs	1,092,000,000	1,083,000,000
Deferred gain from the sale of IQOS System commercialization rights	0	2,700,000,000
Other liabilities	1,324,000,000	324,000,000
Total liabilities	40,928,000,000	40,877,000,000
Contingencies (Note 13)
Stockholders’ Equity (Deficit)
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued)	935,000,000	935,000,000
Additional paid-in capital	5,880,000,000	5,887,000,000
Earnings reinvested in the business	30,340,000,000	29,792,000,000
Accumulated other comprehensive losses	(2,709,000,000)	(2,771,000,000)
Cost of repurchased stock (1,030,214,027 shares at June 30, 2023 and 1,020,427,195 shares at December 31, 2022)	(38,273,000,000)	(37,816,000,000)
Total stockholders’ equity (deficit) attributable to Altria	(3,827,000,000)	(3,973,000,000)
Noncontrolling interests	50,000,000	50,000,000
Total stockholders’ equity (deficit)	(3,777,000,000)	(3,923,000,000)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 37,151,000,000	$ 36,954,000,000